HemOnc.org - A Free Hematology/Oncology Reference

Regimens: 2,217 Regimen variants: 3,151
Solid Tumors Malignant Hematology Transplant Classical Hematology
Mobile Version Editorial Board Desktop Version
Disease index Drug index Regimen index General reference
If this is your first time visiting, please go to the tutorial page or just start exploring!

Links to all main disease pages

Solid Tumors
Breast Oncology
Breast cancer Breast cancer, HER-2 positive Breast cancer, triple negative (TNBC)
Dermatologic Oncology
Melanoma Melanoma, BRAF-mutated Skin, basal & squamous cancer Merkel cell carcinoma
Endocrine Oncology
Adrenocortical carcinoma Neuroendocrine tumors Pancreatic NET Pheochromocytoma
Thyroid cancer
Gastrointestinal Oncology
Anal cancer Cholangiocarcinoma Colon cancer Esophageal cancer
Gastric cancer Gastrointestinal stromal tumor (GIST) Hepatocellular carcinoma Periampullary adenocarcinoma
Pancreatic cancer Pancreatic NET Rectal cancer
Genitourinary Oncology
Bladder cancer Penile cancer Prostate cancer Renal cancer (RCC)
Testicular cancer
Gynecologic Oncology
Cervical cancer Ovarian cancer Uterine cancer
Head & Neck Oncology
Head and neck cancer Thyroid cancer
Anaplastic glioma Glioblastoma Low-grade glioma Meningioma
CNS leukemia CNS lymphoma
Pediatric Oncology
Bone sarcoma Ewing's sarcoma Gastrointestinal stromal tumor (GIST) Osteosarcoma
Soft tissue sarcoma (STS) Vascular sarcoma
Thoracic Oncology
Esophageal cancer Lung cancer, non-small cell (NSCLC) NSCLC, ALK-positive NSCLC, BRAF-mutated
NSCLC, EGFR-mutated Lung cancer, small cell (SCLC) Mesothelioma Thymoma
MSI-H or dMMR Adenocarcinoma of unknown primary NET of unknown primary SCC of unknown primary

back to top
Malignant Hematology
Acute leukemias
Acute myeloid leukemia (AML) AML, FLT3-positive AML, IDH-mutated Acute promyelocytic leukemia (APL)
B-cell acute lymphoblastic leukemia (B-ALL) B-ALL, Ph+ T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL)
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML) Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Myelodysplastic syndrome Primary & secondary myelofibrosis Polycythemia vera (PV) Systemic mastocytosis
Aggressive lymphomas
Burkitt lymphoma (BL) or Burkitt-like lymphoma CNS lymphoma Diffuse large B-cell lymphoma (DLBCL) HIV-associated lymphoma
Hodgkin lymphoma (HL) Mantle cell lymphoma (MCL) Mediastinal gray-zone lymphoma (MGZL) Primary mediastinal B-cell lymphoma (PMBL)
Transformed lymphoma (TL)
Indolent lymphomas
Chronic lymphocytic leukemia (CLL/SLL) Follicular lymphoma (FL) Hairy cell leukemia (HCL) Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)
Marginal zone lymphoma (MZL) Waldenström macroglobulinemia (WM/LPL)
Plasma cell dyscrasias
Light-chain (AL) amyloidosis Multiple myeloma (MM) Plasma cell leukemia
T-cell and NK-cell neoplasms
Adult T-cell leukemia-lymphoma (ATLL) Anaplastic large cell lymphoma (ALCL) Cutaneous T-cell lymphoma (CTCL) Extranodal NK/T-cell lymphoma, nasal type
Large granular lymphocytic (LGL) leukemia NK/T-cell lymphoma Peripheral T-cell Lymphoma (PTCL)
Lymphoproliferative disorders
Castleman disease Post-transplant lymphoproliferative disorder (PTLD)
Histiocyte disorders
Erdheim-Chester disease Hemophagocytic lymphohistiocytosis (HLH) Langerhans cell histiocytosis

back to top
Stem cell mobilization Allogeneic HSCT Autologous HSCT Graft versus host disease (GVHD)

back to top
Classical Hematology
Aplastic anemia Atypical hemolytic-uremic syndrome (aHUS) Autoimmune cytopenias Autoimmune thrombocytopenic purpura (ITP)
Coagulopathies Cold agglutinin disease Paroxysmal nocturnal hemoglobinuria (PNH) Sickle cell anemia
Thrombotic thrombocytopenic purpura (TTP) Venous thromboembolism (VTE)

Additional Information

Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes continuous peer review.

Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

  1. Creating a database of chemotherapy agents and other medications.
  2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
  3. Sample order sets and examples of supportive medications used with treatment regimens
  4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

  1. Creating summaries of pivotal clinical trials
  2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
  3. Checklists for common clinical scenarios/diseases
  4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.